Literature DB >> 30101615

Recruitment and retention of the Hardest-to-Reach families in community-based asthma interventions.

Hillary Goldman1, Maria Fagnano1, Tamara T Perry2, Ariel Weisman1, Amanda Drobnica1, Jill S Halterman1.   

Abstract

BACKGROUND/AIMS: Engaging underserved populations in research requires substantial effort for recruitment and retention. The objective of this study is to describe the effort needed to recruit and retain urban participants in pediatric asthma studies and to characterize the Hardest-to-Reach group by demographics and asthma severity.
METHODS: We included 311 children (3-10 years) with persistent asthma enrolled in two school-based asthma interventions in Rochester, NY. Contact logs were collected at four time points (baseline, 2 month, 4 month, 6 month). We defined "Hardest-to-Reach" (vs "Easier-to-Reach") as being unable to reach a family by telephone at any given contact attempt due to disconnected or wrong numbers. Chi-square and Mann-Whitney tests were used to compare groups.
RESULTS: Overall, we enrolled 311 children (60% Black, 29% Hispanic, 70% Medicaid, response rate 70%). On average, 3.1 contact attempts were required for recruitment (range 1-15), and 35% required rescheduling at least once for the enrollment visit. All but 12 participants completed each follow-up (retention rate = 96%). Completion of follow-ups required an average of 7.6 attempts; we considered 38% of caregivers "Hardest-to-Reach." Caregivers in the Hardest-to-Reach group were slightly younger (33 vs 36 years, p = 0.007) with more depressive symptoms (41% vs 29%, p = 0.035) and smokers in the home (59% vs 48%, p = 0.048). Furthermore, more of the Hardest-to-Reach children had moderate-severe versus mild persistent asthma (64% vs 52%, p = 0.045). Importantly, even the Easier-to-Reach families required many contact attempts, with 52% having >5 attempts for at least one follow-up.
CONCLUSION: In conclusion, we found that among an already vulnerable population, the Hardest-to-Reach families demonstrated higher risk and had children with significantly worse asthma. This study highlights the importance of persistence in reaching those in greatest need.

Entities:  

Keywords:  Recruitment and retention; asthma; hard-to-reach; implementation research; pediatrics; underserved

Mesh:

Year:  2018        PMID: 30101615      PMCID: PMC6218290          DOI: 10.1177/1740774518793598

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  46 in total

1.  Distrust, race, and research.

Authors:  Giselle Corbie-Smith; Stephen B Thomas; Diane Marie M St George
Journal:  Arch Intern Med       Date:  2002-11-25

2.  Strategies for recruitment and retention of participants in clinical trials.

Authors:  Jeffrey L Probstfield; Robert L Frye
Journal:  JAMA       Date:  2011-10-26       Impact factor: 56.272

3.  Measuring environmental tobacco smoke exposure in infants and young children through urine cotinine and memory-based parental reports: empirical findings and discussion.

Authors:  G E Matt; D R Wahlgren; M F Hovell; J M Zakarian; J T Bernert; S B Meltzer; J L Pirkle; S Caudill
Journal:  Tob Control       Date:  1999       Impact factor: 7.552

Review 4.  Reporting attrition in randomised controlled trials.

Authors:  Jo C Dumville; David J Torgerson; Catherine E Hewitt
Journal:  BMJ       Date:  2006-04-22

5.  Recruitment and retention of children in longitudinal research.

Authors:  Beth Ely; Camille Coleman
Journal:  J Spec Pediatr Nurs       Date:  2007-07       Impact factor: 1.260

6.  Racial and ethnic disparities in asthma medication usage and health-care utilization: data from the National Asthma Survey.

Authors:  Deidre Crocker; Clive Brown; Ronald Moolenaar; Jeanne Moorman; Cathy Bailey; David Mannino; Fernando Holguin
Journal:  Chest       Date:  2009-06-30       Impact factor: 9.410

7.  Trends in the cost of illness for asthma in the United States, 1985-1994.

Authors:  K B Weiss; S D Sullivan; C S Lyttle
Journal:  J Allergy Clin Immunol       Date:  2000-09       Impact factor: 10.793

8.  Increasing adherence to inhaled steroid therapy among schoolchildren: randomized, controlled trial of school-based supervised asthma therapy.

Authors:  Lynn B Gerald; Leslie A McClure; Joan M Mangan; Kathy F Harrington; Linda Gibson; Sue Erwin; Jody Atchison; Roni Grad
Journal:  Pediatrics       Date:  2009-02       Impact factor: 7.124

Review 9.  Recruitment and retention of children in behavioral health risk factor studies: REACH strategies.

Authors:  Stephanie Schoeppe; Melody Oliver; Hannah M Badland; Matthew Burke; Mitch J Duncan
Journal:  Int J Behav Med       Date:  2014

10.  Variations in asthma hospitalizations and deaths in New York City.

Authors:  W Carr; L Zeitel; K Weiss
Journal:  Am J Public Health       Date:  1992-01       Impact factor: 9.308

View more
  4 in total

1.  A community-based asthma program: Study design and methods of RVA Breathes.

Authors:  Robin S Everhart; Suzanne E Mazzeo; Rosalie Corona; Rachel L Holder; Leroy R Thacker; Michael S Schechter
Journal:  Contemp Clin Trials       Date:  2020-08-19       Impact factor: 2.226

2.  Association Between Participant Contact Attempts and Reports of Being Bothered in a National, Longitudinal Cohort Study of ARDS Survivors.

Authors:  Michelle N Eakin; Thomas Eckmann; Victor D Dinglas; Ayodele A Akinremi; Megan Hosey; Ramona O Hopkins; Dale M Needham
Journal:  Chest       Date:  2020-03-17       Impact factor: 9.410

3.  Evaluation of a Program to Reduce Home Environment Risks for Children with Asthma Residing in Urban Areas.

Authors:  Brandon Workman; Andrew F Beck; Nicholas C Newman; Laura Nabors
Journal:  Int J Environ Res Public Health       Date:  2021-12-24       Impact factor: 3.390

4.  Recruiting people facing social disadvantage: the experience of the Free Meds study.

Authors:  Pauline Norris; Kimberly Cousins; Marianna Churchward; Shirley Keown; Mariana Hudson; Leina Isno; Leilani Pereira; Jacques Klavs; Lucy Linqing Tang; Hanne Roberti; Alesha Smith
Journal:  Int J Equity Health       Date:  2021-06-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.